Related Experiment Videos

Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties

Chi H Trinh1, David P Smith, Arnout P Kalverda

  • 1Astbury Centre for Structural Molecular Biology, School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.

Insights

The crystal structure of monomeric human beta-2-microglobulin (beta(2)m) reveals structural changes that promote amyloid fibril formation. This finding offers insights into dialysis-related amyloidosis, a complication of renal failure.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Medical Biochemistry

Background:

  • Dialysis-related amyloidosis is caused by the accumulation of beta-2-microglobulin (beta(2)m) due to renal failure.
  • Dissociation of beta(2)m from the HLA complex is the initial step in amyloid formation.

Purpose of the Study:

  • To determine the crystal structure of monomeric human beta(2)m.
  • To understand the structural basis of beta(2)m aggregation and amyloid formation.

Main Methods:

  • X-ray crystallography at 1.8-A resolution.
  • Solution studies using proton nuclear magnetic resonance ((1)H NMR).

Main Results:

  • The crystal structure of monomeric beta(2)m shows significant structural alterations compared to HLA-bound beta(2)m.
  • A beta bulge restructures into a new beta strand, creating an aggregation-competent surface.
  • Solution studies confirm the existence of this aggregation-prone species in solution.

Conclusions:

  • The identified structural changes in monomeric beta(2)m facilitate amyloid formation.
  • This structure represents a key intermediate in the pathogenesis of dialysis-related amyloidosis.
  • Findings provide crucial insights into the mechanism of amyloidogenesis from a normally soluble protein.

Related Concept Videos